Stocks

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Name	Symbol	Analysis date	Close	+/- %
Acer Incorporated	AC5G	Apr 17, 2025	3.20	0.00
ACERINOX ADR 1/2/EO-,25	ACE	Apr 17, 2025	4.66	+1.75
Acerinox SA	ACE1	Apr 17, 2025	9.63	0.00
Achieve Life Sciences, Inc. -	SP4P	Apr 17, 2025	1.83	-2.24
Achilles Therapeutics plc - American Depositary Shares	698	Apr 17, 2025	1.33	0.00
ACI Worldwide, Inc.	TSA	Apr 17, 2025	45.20	-0.88
ACINQUE S.P.A. EO 1	YA2	Apr 17, 2025	2.00	0.00
Ackermans & van Haaren NV	B3K	Apr 17, 2025	202.00	+3.38
Aclara Resources Inc	JD1	Apr 17, 2025	0.40	+43.17
Aclaris Therapeutics, Inc.	8AT	Apr 17, 2025	0.99	-3.36
ACM Research, Inc. - Class A	813	Apr 17, 2025	17.22	-1.46
Acma Ltd	AAX1	Apr 17, 2025	0.01	-42.86
Acme United Corporation.	UT1	Apr 17, 2025	35.00	+2.94
Acom Co Ltd	AK5	Apr 17, 2025	2.24	+4.67
aconnic AG	CFC	Apr 17, 2025	0.92	-9.41
Acotec Scientific Holdings Limited	7W3	Apr 17, 2025	0.76	-1.94
AcouSort	4SA	Apr 17, 2025	0.27	+4.33
ACRES Commercial Realty D Pref	R9L0	Apr 17, 2025	18.60	0.00
Acrinova A	9M0	Apr 17, 2025	0.88	-6.91
ACROUD	7NG	Apr 17, 2025	0.00	0.00
Acrow Formwork and Construction Services Limited	59Y	Apr 17, 2025	0.58	0.00
Acrux Ltd	FJY	Apr 17, 2025	0.01	-15.79
ACS A.DE C.ADR 1/5/EO-,50	OCI	Apr 17, 2025	10.40	+4.00
ACS Actividades de Construccion y Servicios SA	OCI1	Apr 17, 2025	51.15	+0.20
Actia Group	AG9	Apr 17, 2025	2.73	+1.49
Actic Group	8XA	Apr 17, 2025	1.08	-7.69
Actinium Pharmaceuticals, Inc. (Delaware)	7AY1	Apr 17, 2025	1.08	-4.50
Actinogen Medical Limited	3AC	Apr 17, 2025	0.01	+7.69
Active Biotech	BTPC	Apr 17, 2025	0.01	+42.50
ActiveOps Plc	95D	Apr 17, 2025	0.95	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.